71734107 — BAUSCH HEALTH COS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying 71734107?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 5 tracked investors who changed their 71734107 position last quarter, 5 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).
- +5 tracked investors added or increased positions last quarter (Paul Tudor Jones, Izzy Englander, Ken Griffin, …)
- +6 tracked investors reported holding 71734107 at their latest filing
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About BAUSCH HEALTH COS INC (71734107)
BAUSCH HEALTH COS INC (71734107) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $15M. Across recent filings, tracked investors recorded 10 new positions, 2 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in 71734107
How many top investors track 71734107
Several tracked investors have exposure.
71734107 Ownership Composition
How BAUSCH HEALTH COS INC is held across tracked investor types, based on reported 13F positions.
- Other60.1%
- Hedge Funds39.9%
Tracked investors reporting 71734107
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.6MValue$8.6M% Portfolio0.00%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares436.8KValue$2.4M% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares1.4MValue$7.3M% Portfolio0.01%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares670.4KValue$3.6M% Portfolio0.02%
- Daniel LoebDec 31, 2025Third Point LLCShares350KValue$2.4M% Portfolio0.03%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares11.8KValue$63.7K% Portfolio0.00%
Recent activity
- $82KFeb 17, 2026
- $63.7KMay 15, 2026
- $12.8MFeb 17, 2026
- $2.4MMay 15, 2026
- New$9.5MFeb 17, 2026
- New$8.6MMay 15, 2026
- New$2.4MFeb 17, 2026
- New$7.3MMay 15, 2026
- Increased$3.6M(36.97%)May 15, 2026
- Increased$3.4M(12.11%)Feb 13, 2026
- New$6.2MNov 14, 2025
- New$2.8MNov 13, 2025
Frequently asked questions
- How many institutional investors hold 71734107?
- 6 tracked institutional investors disclosed a position in 71734107 (BAUSCH HEALTH COS INC) in their most recent 13F filing.
- Who is the largest institutional holder of 71734107?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in 71734107, valued at $15M.
- Did institutional ownership of 71734107 increase or decrease?
- Across recent 13F filings, tracked investors recorded 10 new positions, 2 increased, 0 reduced, and 0 fully exited 71734107.
- Where does this 71734107 ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.